logo
bearish

WuXi AppTec

WuXi AppTec (2359.HK/603259.CH) 2023 Results - Time to Prepare for the Worst

556 Views20 Mar 2024 08:55
WuXi AppTec’s 2023 results were disappointing. 2024 performance guidance is meaningless due to the increasingly intense geopolitical conflicts. It's time to prepare for the worst impact on valuation.
Xinyao has highlighted this Insight as a Top Pick
Boomeranged on Tue, 2 Apr 2024 09:20
Here are new updates: Mike Gal­lagher & Ra­ja Kr­ish­namoor­thi sent a letter to the Pen­ta­gon to push for related Chi­na com­pa­nies/sub­sidiaries to be added to a Pen­ta­gon list of firms that al­leged­ly work with the Chi­nese mil­i­tary. Meanwhile, of­fi­cials from mul­ti­ple US agencies told the sen­a­tors they were con­cerned about WuXi trans­ferred US client’s IP to Chinese au­thor­i­ties.
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
ChinaHealth CareEquity Bottom-UpThematic (Sector/Industry)
WuXi AppTec (2359 HK)
View More »

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.30.3

x